Abstract
N -Cbz-protected amino acids reacted
with various arylamines in the presence of methanesulfonyl
chloride and N -methylimidazole in dichloromethane
to give the corresponding arylamides in high yields. No obvious
racemization was observed under the mild conditions.
Key words
amino acid arylamides -
N -Cbz-protected
amino acids - condensation - steric hindrance - enantioretention
References and Notes
<A NAME="RW13010ST-1A">1a </A>
Yin H.
Frederick K.
Liu D.
Wand A.
DeGrado W.
Org. Lett.
2006,
8:
223
<A NAME="RW13010ST-1B">1b </A>
Vinogradov S.
Org.
Lett.
2005,
7:
1761
<A NAME="RW13010ST-1C">1c </A>
Yin H.
Gerlach L.
Miller M.
Moore D.
Liu D.
Vilaire G.
Bennett J.
DeGrado W.
Bioorg. Med. Chem. Lett.
2006,
16:
3380
<A NAME="RW13010ST-1D">1d </A>
Kirkland T.
Adler M.
Bauman J.
Chen M.
Haeggstrm J.
King B.
Kochanny M.
Liang A.
Mendoza L.
Phillips G.
Bioorg. Med. Chem.
2008,
16:
4963
<A NAME="RW13010ST-1E">1e </A>
Foss JF.
Mathews T.
Kharel Y.
Kennedy P.
Snyder A.
Davis M.
Lynch K.
Macdonald T.
Bioorg. Med. Chem.
2007,
15:
663
<A NAME="RW13010ST-2">2 </A>
Svendsen L.
Blomback B.
Blomback M.
Olsson P.
Thromb. Res.
1972,
1:
267
<A NAME="RW13010ST-3A">3a </A>
Zimmerman M.
Yurewicz E.
Patel G.
Anal. Biochem.
1976,
70:
258
<A NAME="RW13010ST-3B">3b </A>
Fujiwara K.
Tsuru D.
J. Biochem.
1978,
83:
1145
<A NAME="RW13010ST-3C">3c </A>
Sharma S.
Castellino F.
Thromb. Res.
1990,
57:
127
<A NAME="RW13010ST-4">4 </A>
Okada Y.
Tsuda Y.
Hirata A.
Nagamatsu Y.
Okamoto U.
Chem. Pharm.
Bull.
1982,
30:
4060
<A NAME="RW13010ST-5A">5a </A>
Nedev H.
Nabarisoa H.
Haertle T.
Tetrahedron Lett.
1993,
34:
4201
<A NAME="RW13010ST-5B">5b </A>
Pozdnev V.
Int.
J. Peptide Protein Res.
1994,
44:
36
<A NAME="RW13010ST-5C">5c </A>
Schutkowski M.
Mrestani-Klaus C.
Neubert K.
Int.
J. Peptide Protein Res.
1995,
45:
257
<A NAME="RW13010ST-5D">5d </A>
Beniton N.
Lee Y.
Steinaur R.
Chen F.
Int. J. Peptide Protein Res.
1992,
40:
559
<A NAME="RW13010ST-6">6 </A>
Kato T.
Nagatsu T.
Kimura T.
Sakakibara S.
Experientia
1978,
19:
351
<A NAME="RW13010ST-7A">7a </A>
Zimmerman M.
Ashe B.
Yurewicz E.
Patel G.
Anal. Biochem.
1977,
78:
47
<A NAME="RW13010ST-7B">7b </A>
Teno N.
Wanaka K.
Okada Y.
Tsuda Y.
Okamoto U.
Hijikata-Okunomiya A.
Naito T.
Okamoto S.
Chem. Pharm. Bull.
1991,
39:
2340
<A NAME="RW13010ST-8A">8a </A>
Haverback B.
Dyce B.
Bundy H.
Edmondson H.
Am. J.
Med.
1960,
29:
424
<A NAME="RW13010ST-8B">8b </A>
Bundy H.
Arch.
Biochem. Biophys.
1963,
102:
416
<A NAME="RW13010ST-9">9 </A>
Wu X.
Hu L.
J. Org. Chem.
2007,
72:
765
<A NAME="RW13010ST-10">10 </A>
Nicolaou K.
Baran P.
Zhong Y.
Choi H.
Fong K.
He Y.
Yoon W.
Org. Lett.
1999,
1:
883
<A NAME="RW13010ST-11">11 </A>
Woo J.
Fenster E.
Dake G.
J. Org. Chem.
2004,
69:
8984
<A NAME="RW13010ST-12A">12a </A>
Wakasugi K.
Iida A.
Misaki T.
Nishii Y.
Tanabe Y.
Adv. Synth. Catal.
2003,
345:
1209
<A NAME="RW13010ST-12B">12b </A>
Nakatsuji H.
Ueno K.
Misaki T.
Tanabe Y.
Org. Lett.
2008,
10:
2131
<A NAME="RW13010ST-13">13 </A>
Typical Procedure
for the Preparation of Amino Acid Arylamides : MeIm (25.0 mmol)
was added to a stirred solution of Cbz-Phe (10.0 mmol) in CH2 Cl2 (15
mL) at 0-5 ˚C, and the mixture was stirred for
10 min. MsCl (10.0 mmol) in CH2 Cl2 (1.0 mL)
was added to the mixture under -5 ˚C.
After the mixture was stirred under that temperature for 20 min,
aniline (9.0 mmol) was added. Then the mixture was stirred at r.t.
for 2 h. H2 O (100 mL) was added to the mixture, which
was extracted with additional CH2 Cl2 (100 mL).
The organic layer was washed with sat. NaCl solution (3 × 50
mL) and dried with anhyd Na2 SO4 . The solvent
was removed by evaporation under reduced pressure. Purification
by chromatography on silica gel (CH2 Cl2 -MeOH)
gave 3b as a white solid; mp 169-170 ˚C; [α]D
²5 46.0
(c = 0.2, DMSO); ee >99.5%. ¹ H
NMR (400 MHz, DMSO): δ = 2.88 (dd, 1 H), 3.03
(dd, 1 H), 4.43 (m, 1 H), 4.99 (s, 2 H), 5.43 (br s, 1 H), 7.00-7.60
(m, 15 H), 10.04 (br s, 1 H). HRMS (ESI+ ): m /z [M + Na+ ] calcd
for C23 H22 N2 O3 : 397.1528;
found: 397.1530.